Radiopharmaceuticals / Radiochemistry
The CURIC collaborates with the PharmaLogic LLC radiopharmacy facility. PharmaLogic operates two GE PETTrace cyclotrons that produces PET radioisotopes for the manufacturing and distribution of clinical and research PET radiopharmaceuticals.
Radiopharmaceuticals available for clinical and research applications:
- 18F-FDG (oncology, neuroimaging)
- 18F-Pylarify (PSMA tracer for prostate cancer)
- 18F-Vizamyl (Flutemetamol, amyloid tracer for Alzheimer)
- 18F-Neuraseq (Florbetaben, amyloid tracer for Alzheimer)
- 68Ga-NETSPOT (DOTATE, for neuroendocrine tumors)
- 68Ga-Illuccix (PSMA-11 for prostate cancer)
Radiopharmaceuticals available for research applications only:
- 18F-FET (fluoroethyl-tyrosine, for brain tumors and metastases)
- 11C- Acetate (metabolic diseases and oncology)
Coming soon:
- 18F-Flyrcado (Flurpiridaz, for cardiac perfusion)
For radiopharmaceuticals not available through PharmaLogic, CURIC works with other vendors including Cardinal Health, PETNET Solutions Inc., and Jubilant Radiopharma.
The department offers Nuclear Medicine expertise and support for collaboration on the specific needs for any radiochemistry portion of human subject protocols.
